Bleeding significantly lower in patients receiving shorter DAPT
Two large randomized studies in Asia show at least non-inferior results for patients receiving shorter dual antiplatelet therapy (DAPT) compared to standard, 12-month DAPT while showing significantly less bleeding in patients receiving shorter DAPT, according to results presented Monday at the American College of Cardiology Scientific Sessions 2019 in New Orleans.